Van Oene Mark's Form 4 filing
Pacific Biosciences of California, Inc. (PACB) · filed Mar 6, 2023
- Accession no.
- 0001299130-23-000040
- Filed
- Mar 6, 2023
- Trade date
- Mar 2-3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $59.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Van Oene MarkCIK 0001707477 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | Common Stock | AGrant or awardAcquired | +328,500 | $0.00 | $0 | 972,139 | Direct | |
| Mar 3, 2023 | Common Stock | SSaleDisposed | −6,268 | $9.49 | −$59,483.32 | 965,871 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.